Venous thrombosis: preventing clots in patients at risk.
Phillippe
Haley M
HM
Auburn University, Harrison School of Pharmacy, Auburn, AL, USA. mccrahl@auburn.edu
Sparkman
Amanda Y
AY
D000925:Anticoagulants / Q000009:adverse effects; D016736:Antiphospholipid Syndrome / Q000150:complications; D001780:Blood Coagulation Tests; D005165:Factor V / Q000235:genetics; D005260:Female; D005820:Genetic Testing; D006493:Heparin / Q000009:adverse effects; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications / Q000175:diagnosis; D009154:Mutation; D009369:Neoplasms / Q000150:complications; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011516:Prothrombin / Q000235:genetics; D013921:Thrombocytopenia / Q000139:chemically induced; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin; D006493:Heparin